Gotowa bibliografia na temat „T cell”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „T cell”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "T cell"
Ohshima, Kôichi, Junji Suzumiya i Masahiro Kikuchi. "T cell rich B cell lymphoma". Journal of the Japan Society of the Reticuloendothelial System 36, nr 5-6 (1996): 391–93. http://dx.doi.org/10.3960/jslrt1961.36.391.
Pełny tekst źródłaY, Elshimali. "Chimeric Antigen Receptor T-Cell Therapy (Car T-Cells) in Solid Tumors, Resistance and Success". Bioequivalence & Bioavailability International Journal 6, nr 1 (2022): 1–6. http://dx.doi.org/10.23880/beba-16000163.
Pełny tekst źródłaRobbins, Paul F. "T-Cell Receptor–Transduced T Cells". Cancer Journal 21, nr 6 (2015): 480–85. http://dx.doi.org/10.1097/ppo.0000000000000160.
Pełny tekst źródłaCPK, Cheung. "T Cells, Endothelial Cell, Metabolism; A Therapeutic Target in Chronic Inflammation". Open Access Journal of Microbiology & Biotechnology 5, nr 2 (2020): 1–6. http://dx.doi.org/10.23880/oajmb-16000163.
Pełny tekst źródłaLamers, Cor H. J., Sabine van Steenbergen-Langeveld, Mandy van Brakel, Corrien M. Groot-van Ruijven, Pascal M. M. L. van Elzakker, Brigitte van Krimpen, Stefan Sleijfer i Reno Debets. "T Cell Receptor-Engineered T Cells to Treat Solid Tumors: T Cell Processing Toward Optimal T Cell Fitness". Human Gene Therapy Methods 25, nr 6 (grudzień 2014): 345–57. http://dx.doi.org/10.1089/hgtb.2014.051.
Pełny tekst źródłaHill, LaQuisa C., Rayne H. Rouce i Maksim Mamonkin. "CAR T-Cells for T-cell Lymphoma". Clinical Lymphoma Myeloma and Leukemia 21 (wrzesień 2021): S173—S174. http://dx.doi.org/10.1016/s2152-2650(21)01255-6.
Pełny tekst źródłaAkatsuka, Yoshiki. "IV. T-cell Receptor-engineered T Cells". Nihon Naika Gakkai Zasshi 108, nr 7 (10.07.2019): 1384–90. http://dx.doi.org/10.2169/naika.108.1384.
Pełny tekst źródłaRimpo, Kenji, Yumiko Kagawa i Tetsushi Yamagami. "T-cell-rich B-cell lymphoma in a dog". Journal of Japan Veterinary Cancer Society 4, nr 1 (2013): 1–5. http://dx.doi.org/10.12951/jvcs.2012-001.
Pełny tekst źródłaZinkernagel, Rolf M., Demetrius Moskophidis, Thomas Kundig, Stephan Oehen, Hanspeter Pircher i Hans Hengartner. "Effector T-Cell Induction and T-Cell Memory versus Peripheral Deletion of T Cells". Immunological Reviews 133, nr 1 (czerwiec 1993): 199–223. http://dx.doi.org/10.1111/j.1600-065x.1993.tb01517.x.
Pełny tekst źródłaYano, Hiroki, Takashi Ishida, Atsushi Inagaki, Toshihiko Ishii, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida, Atae Utsunomiya i Ryuzo Ueda. "Regulatory T-cell function of adult T-cell leukemia/lymphoma cells". International Journal of Cancer 120, nr 9 (2007): 2052–57. http://dx.doi.org/10.1002/ijc.22536.
Pełny tekst źródłaRozprawy doktorskie na temat "T cell"
Sarris, Milka. "Dynamics of helper T cell and regulatory T cell interactions with dendritic cells". Thesis, University of Cambridge, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.611896.
Pełny tekst źródłaCarson, Bryan David. "Impaired T cell receptor signaling in regulatory T cells /". Thesis, Connect to this title online; UW restricted, 2006. http://hdl.handle.net/1773/8337.
Pełny tekst źródłaLloyd, Angharad. "Gene editing in T-cells and T-cell targets". Thesis, Cardiff University, 2016. http://orca.cf.ac.uk/98512/.
Pełny tekst źródłaStefkova, Martina. "Regulatory T cells control the CD4 T cell repertoire". Doctoral thesis, Universite Libre de Bruxelles, 2016. https://dipot.ulb.ac.be/dspace/bitstream/2013/233151/3/Table.pdf.
Pełny tekst źródłaRecent studies conducted in mice and humans have suggested a role for the TCR repertoire diversity in immune protection against pathogens displaying high antigenic variability. To study the CD4 T cell repertoire, we used a mouse model in which T cells transgenically express the TCRβ chain of a TCR specific to a MHCII-restricted peptide, env122-141. Upon immunization with peptide-pulsed dendritic cells, antigen-specific Vα2+ CD4+ T cells rapidly expand and display a restricted TCRα repertoire. In particular, analysis of receptor diversity by high-throughput TCR sequencing in immunized mice suggests the emergence of a broader CDR3 Vα2 repertoire in Treg-depleted mice. These results suggest that Tregs may play a role in the restriction of the CD4 T cell repertoire during an immune response, raising therefore the possibility that in addition to controlling the magnitude of an immune response, regulatory cells may also control the diversity of TCRs in response to antigen stimulation.
Doctorat en Sciences
info:eu-repo/semantics/nonPublished
Smith, Trevor Robert Frank. "Modulation of CD4+ T cell responses by CD4+CD25+ regulatory T cells and modified T cell epitopes". Thesis, Imperial College London, 2004. http://hdl.handle.net/10044/1/11317.
Pełny tekst źródłaSommermeyer, Daniel. "Generation of dual T cell receptor (TCR) T cells by TCR gene transfer for adoptive T cell therapy". Doctoral thesis, Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2010. http://dx.doi.org/10.18452/16051.
Pełny tekst źródłaThe in vitro generation of T cells with a defined antigen specificity by T cell receptor (TCR) gene transfer is an efficient method to create cells for immunotherapy. One major challenge of this strategy is to achieve sufficiently high expression levels of the therapeutic TCR. As T cells expressing an endogenous TCR are equipped with an additional TCR, there is a competition between therapeutic and endogenous TCR. Before this work was started, it was not known which TCR is present on the cell surface after TCR gene transfer. Therefore, we transferred TCR genes into murine and human T cells and analyzed TCR expression of endogenous and transferred TCR by staining with antibodies and MHC-multimers. We found that some TCR have the capability to replace other TCR on the cell surface, which led to a complete conversion of antigen specificity in one model. Based on these findings we proposed the concept of ‘‘strong’’ (well expressed) and “weak” (poorly expressed) TCR. In addition, we found that a mouse TCR is able to replace both “weak” and “strong” human TCR on human cells. In parallel to this result, it was reported that the constant (C)-regions of mouse TCR were responsible for the improved expression of murine TCR on human cells. This led to a strategy to improve human TCR by exchanging the C-regions by their murine counterparts (murinization). However, a problem of these hybrid constructs is the probable immunogenicity. Therefore, we identified the specific parts of the mouse C-regions which are essential to improve human TCR. In the TCRalpha C-region four and in the TCRbeta C-region five amino acids were identified. Primary human T cells modified with TCR containing these nine “murine” amino acids showed an increased function compared to cells modified with wild type TCR. For TCR gene therapy the utilization of these new C-regions will reduce the amount of foreign sequences and thus the risk of immunogenicity of the therapeutic TCR.
Tyznik, Aaron Jacob. "CD4+ T cell help for CD8+ T cell responses /". Thesis, Connect to this title online; UW restricted, 2007. http://hdl.handle.net/1773/8314.
Pełny tekst źródłaButcher, Sarah A. "T cell receptor genes of influenza A haemagglutinin specific T cells". Thesis, University College London (University of London), 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.315271.
Pełny tekst źródłaRaeiszadeh, Mohammad. "Reconstitution of CMV-specific T-cells following adoptive T-cell immunotherapy and haematopoietic stem cell transplantation". Thesis, University of Birmingham, 2016. http://etheses.bham.ac.uk//id/eprint/6968/.
Pełny tekst źródłaKanazawa, Nobuo. "Fractalkine and macrophage-derived chemokine : T cell attracting chemokines expressed in T cell area dendritic cells". Kyoto University, 2000. http://hdl.handle.net/2433/180886.
Pełny tekst źródłaKsiążki na temat "T cell"
1956-, Zhang Jingwu, i Cohen Irun R, red. T-cell vaccination. New York: Nova Biomedical Books, 2008.
Znajdź pełny tekst źródłaKearse, Kelly P. T Cell Protocols. New Jersey: Humana Press, 1999. http://dx.doi.org/10.1385/1592596827.
Pełny tekst źródłaLugli, Enrico, red. T-Cell Differentiation. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6548-9.
Pełny tekst źródłaRainger, George Edward, i Helen M. Mcgettrick, red. T-Cell Trafficking. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6931-9.
Pełny tekst źródłaFoss, Francine, red. T-Cell Lymphomas. Totowa, NJ: Humana Press, 2013. http://dx.doi.org/10.1007/978-1-62703-170-7.
Pełny tekst źródłaVerma, Navin Kumar, red. T-Cell Motility. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9036-8.
Pełny tekst źródłaLibero, Gennaro, red. T Cell Protocols. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-527-9.
Pełny tekst źródłaMarelli-Berg, Federica M., i Sussan Nourshargh, red. T-Cell Trafficking. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-461-6.
Pełny tekst źródłaBosselut, Rémy, i Melanie S. Vacchio, red. T-Cell Development. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-2809-5.
Pełny tekst źródłaBosselut, Remy, i Melanie S. Vacchio, red. T-Cell Development. New York, NY: Springer US, 2023. http://dx.doi.org/10.1007/978-1-0716-2740-2.
Pełny tekst źródłaCzęści książek na temat "T cell"
Gooch, Jan W. "T Cell". W Encyclopedic Dictionary of Polymers, 927. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-6247-8_14928.
Pełny tekst źródłaBland, P. W. "Mucosal T Cell-Epithelial Cell Interactions". W Mucosal T Cells, 40–63. Basel: KARGER, 1998. http://dx.doi.org/10.1159/000058714.
Pełny tekst źródłaSimmons, Amie, i José Alberola-Ila. "Retroviral Transduction of T Cells and T Cell Precursors". W T-Cell Development, 99–108. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-2809-5_8.
Pełny tekst źródłaChen, C. H., A. Six, T. Kubota, S. Tsuji, F. K. Kong, T. W. F. Göbel i M. D. Cooper. "T Cell Receptors and T Cell Development". W Current Topics in Microbiology and Immunology, 37–53. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-80057-3_5.
Pełny tekst źródłaYamaguchi, Motoko, i Kensei Tobinai. "NK-Cell Neoplasms". W T-Cell Lymphomas, 87–103. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-170-7_6.
Pełny tekst źródłaSarris, Milka, i Alexander G. Betz. "Live Imaging of Dendritic Cell–Treg Cell Interactions". W Regulatory T Cells, 83–101. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61737-979-6_7.
Pełny tekst źródłaVacchio, Melanie S., Thomas Ciucci i Rémy Bosselut. "200 Million Thymocytes and I: A Beginner’s Survival Guide to T Cell Development". W T-Cell Development, 3–21. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-2809-5_1.
Pełny tekst źródłaWohlfert, Elizabeth A., Andrea C. Carpenter, Yasmine Belkaid i Rémy Bosselut. "In Vitro Analyses of T Cell Effector Differentiation". W T-Cell Development, 117–28. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-2809-5_10.
Pełny tekst źródłaRoss, Jenny O., Heather J. Melichar, Joanna Halkias i Ellen A. Robey. "Studying T Cell Development in Thymic Slices". W T-Cell Development, 131–40. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-2809-5_11.
Pełny tekst źródłaCunningham, Cody A., Emma Teixeiro i Mark A. Daniels. "FTOC-Based Analysis of Negative Selection". W T-Cell Development, 141–49. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-2809-5_12.
Pełny tekst źródłaStreszczenia konferencji na temat "T cell"
Mamonkin, Maksim. "Abstract IA17: CAR T cells for T-cell lymphoma". W Abstracts: AACR Virtual Meeting: Advances in Malignant Lymphoma; August 17-19, 2020. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2643-3249.lymphoma20-ia17.
Pełny tekst źródłavan der Stegen, Sjoukje J. C., Maria Themeli, Justin Eyquem, Jorge Mansilla-Soto i Michel Sadelain. "Abstract 2309: T-cell development from T cell-derived induced pluripotent stem cell". W Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2309.
Pełny tekst źródłaDuan, Zhipu, Zhuohui Lin i Shijie Zhou. "Universal CAR T cell: engineering of universal T cell, modular CAR system, and applications". W 2021 International Conference on Medical Imaging, Sanitation and Biological Pharmacy. Clausius Scientific Press, 2021. http://dx.doi.org/10.23977/misbp.2021036.
Pełny tekst źródłaJakobsen, Bent. "Abstract 2802: Fine-tuning T cell receptors for adoptive T cell therapy". W Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-2802.
Pełny tekst źródłaWilking, Alice, Lili Wang, Benjamin K. Chen, Thomas Huser i Wolfgang Hubner. "Resolving T cell — T cell transfer of HIV-1 by optical nanoscopy". W 2017 Conference on Lasers and Electro-Optics Europe (CLEO/Europe) & European Quantum Electronics Conference (EQEC). IEEE, 2017. http://dx.doi.org/10.1109/cleoe-eqec.2017.8087773.
Pełny tekst źródłaKristensen, Nikolaj Pagh, Christina Heeke, Siri A. Tvingsholm, Anne-Mette Bjerregaard, Arianna Draghi, Amalie Kai Bentzen, Rikke Andersen, Marco Donia, Inge Marie Svane i Sine Reker Hadrup. "Abstract A14: Neoepitope-specific CD8+ T cells in adoptive T-cell transfer". W Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 17-20, 2019; Boston, MA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm19-a14.
Pełny tekst źródłaChen, Gregory M., Changya Chen, Rajat K. Das, Yang-Yang Ding, Bing He, Hannah Kim, David M. Barrett i Kai Tan. "Abstract 4236: A subtype-specific T-cell transcriptomic atlas reveals determinants of T-cell dysfunction in CAR T-cell therapy resistance". W Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-4236.
Pełny tekst źródłaHo, Chen-Ta, i Cheng-Hsien Liu. "Micro T-Switches for Cell Sorting Applications". W ASME 2004 International Mechanical Engineering Congress and Exposition. ASMEDC, 2004. http://dx.doi.org/10.1115/imece2004-61427.
Pełny tekst źródłaEun, So-Young. "Abstract 1645: CEACAM1-blockade for T-cell activation and antitumor T-cell response". W Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-1645.
Pełny tekst źródłaTakahashi, Hideyuki, Paulina Pathria, Ryan Shepard, Ann Shih, Tiani L. Louis i Judith A. Varner. "Abstract A86: PI3Kγ inhibition activates T cell memory and relieves T cell exhaustion". W Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 27-30, 2018; Miami Beach, FL. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm18-a86.
Pełny tekst źródłaRaporty organizacyjne na temat "T cell"
HLADEK, K. L. T Plant Cell Investigation. Office of Scientific and Technical Information (OSTI), wrzesień 2001. http://dx.doi.org/10.2172/807319.
Pełny tekst źródłaBonnett, Megan. CAR T Cell Therapy. Ames (Iowa): Iowa State University, styczeń 2019. http://dx.doi.org/10.31274/cc-20240624-337.
Pełny tekst źródłaDotti, Gianpietro. Improve T Cell Therapy in Neuroblastoma. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2012. http://dx.doi.org/10.21236/ada610046.
Pełny tekst źródłaDotti, Gianpietro. Improve T Cell Therapy in Neuroblastoma. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2014. http://dx.doi.org/10.21236/ada612327.
Pełny tekst źródłaDotti, Gianpietro. Improve T Cell Therapy in Neuroblastoma. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2013. http://dx.doi.org/10.21236/ada594698.
Pełny tekst źródłaDotti, Gianpietro. Improve T Cell Therapy in Neuroblastoma. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2011. http://dx.doi.org/10.21236/ada550874.
Pełny tekst źródłaMedof, M. E. Augmentation of Antitumor T-Cell Responses by Increasing APC T-Cell C5a/C3a-C5aR/C3aR Interactions. Fort Belvoir, VA: Defense Technical Information Center, marzec 2013. http://dx.doi.org/10.21236/ada585489.
Pełny tekst źródłaHLADEK, K. L. T plant cell investigation phase II report. Office of Scientific and Technical Information (OSTI), grudzień 2002. http://dx.doi.org/10.2172/808832.
Pełny tekst źródłaCooper, Laurence. T-Cell Immunotherapies for Treating Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2011. http://dx.doi.org/10.21236/ada554845.
Pełny tekst źródłaChen, Xiuxu, i Jenny E. Gumperz. Human CD1d-Restricted Natural Killer T (NKT) Cell Cytotoxicity Against Myeloid Cells. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2006. http://dx.doi.org/10.21236/ada462826.
Pełny tekst źródła